About the Foundation

The Foundation for Cancer Research Support (RakFond) is a non-profit organization whose main tasks include: financing research and development activities, development of new methods and tools for the prevention, diagnosis and treatment of cancer, promoting the development and improvement of research and scientific activities of research institutions, scientific centers, oncological hospitals, and individual specialists in the field of oncology. The Foundation was founded in 2017 and operates on the territory of the Russian Federation.

NEWS

VIEW ALL

19 Mar

The results of the research supported by the RakFond by Bulatov E.R.

Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising areas of modern basic and clinical oncology. A CAR-T cell is ... далее...

16 Mar

Dear Friends and Colleagues! Today, on March 16, Professor Boris Afanasyev, member of the Foundation’s Scientific Advisory Board, Doctor of Medical Sciences, ... далее...

2 Mar

Report on the results of the Foundation's operations in 2019

A report on the results of the Foundation's operations in 2019 has been posted on our website. It contains the detailed description of supported research, events, ... далее...

13 Feb

ASCO Clinical Cancer Advances 2020

Достижения клинической онкологии – это ежегодный отчет ASCO, которые выделяет наиболее значимые научные достижения прошедшего года и определяют исследовательские приоритеты, которые могут ускорить прогресс в противораковой борьбе. далее...

4 Feb

RakFond Announces a New Competition of Research Projects in Radiation Therapy

Today, on World Cancer Day, the Foundation for Cancer Research Support opens applications submission to the competition of research projects in radiation therapy in oncology. далее...

15 Nov

NEWS OF THE XXIII RUSSIAN ONCOLOGY CONGRESS

В первый день XXIII Российского онкологического конгресса РакФонд и Российское общество клинической онкологии провели совместный мастер-класс, посвященный клиническим исследованиям в онкологии далее...

Articles and Reviews

View All

23 Jul

Highlights of 2020 ASCO Annual Meeting

This year the American Society of Clinical Oncology (ASCO) Annual Meeting was delivered in a new virtual format on May 29-31, 2020 with a record-breaking attenda... далее...

Interviews with experts

RakFond's experts talk in their short interviews about their choice to become an oncologist, which cancer research they could name as their favorite, and why cancer research support is important.

Interview with Tatiana Semiglazova

Interview with Tatiana Semiglazova, MD, DSci, Professor, Head of Department of Innovative Methods of Therapeutic Oncology and Rehabilitation, N.N. Petrov National Medical Research Center of Oncology (St. Petersburg, Russia), Professor at the Department of Oncology, I.I. Mechnikov North-Western State Medical University (St. Petersburg, Russia)...The topic of the interview is the rehabilitation of cancer patients... далее...

Interview with Andrei Gudkov

Interview with Andrei Gudkov, Ph.D., D.Sci., Senior Vice President, Research Technology and Innovation, Chair, Cell Stress Biology, Roswell Park Comprehensive Cancer Center (Buffalo, USA), Member of RakFond's Scientific Advisory Board... Learn about the relationship between cancer and evolution, what the scientists may be proud of, and where the curiosity leads us... далее...

Interview with Katerina Gurova

Interview with Katerina Gurova, M.D., Ph.D., Professor of Oncology, Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center (Buffalo, USA)... Learn about the regulation of reading in the library of genes, the role of the "gene of conscience"... далее...

Interview with Jacek Gronwald

Interview with Jacek Gronwald, PhD, Professor, Department of Genetics and Pathology, Pomeranian Medical University (Szczecin, Poland), Member of RakFond's Scientific Advisory Board. Learn about hereditary cancers, studies of lifestyle factors in oncology... далее...

Interview with Alexey Danilov

Interview with Alexey Danilov, Associate Professor of Medicine, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University (Portland, USA), Member of RakFond's Scientific Advisory Board...Learn about research translation from bench to bedside, the discovery and research of the novel therapies in hematologic malignancies... далее...

Interview with Alexey Tryakin

Interview with Alexey Tryakin, M.D., D.Sci., Chief Scientist, Department of Clinical Pharmacology and Chemotherapy of N.N. Blokhin National Medical Research Center of Oncology (Moscow, Russia)... Learn about the inception of the targeted therapy in oncology, what advantages of participating in clinical trials bring to doctors and patients... далее...

About the Foundation

NEWS

Articles and Reviews

Interviews with experts

Our Supporters